GRACEcast- ASCO LUNG 2020- New Potential Treatments for MET and RET Positive NSCLC Capmatinib-Tabrecta and BLU-667-Pralsetinib
Apr 14, 2021 ·
10m 18s
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
Drs. H. Jack West, David Spigel and Helena Yu discuss new potenteial treatments for MET and RET Positive NSCLC: Capmatinib/Tabrecta and BLU-667/Pralsetinib
Information
| Author | cancerGRACE |
| Organization | cancerGRACE |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
Comments